VRBC.F Stock Overview
Manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Virbac SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €370.00 |
| 52 Week High | €385.60 |
| 52 Week Low | €288.00 |
| Beta | 0.97 |
| 11 Month Change | -3.75% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 8.50% |
| 5 Year Change | n/a |
| Change since IPO | 430.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| VRBC.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 1.8% |
| 1Y | n/a | 21.8% | 24.0% |
Return vs Industry: Insufficient data to determine how VRBC.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how VRBC.F performed against the US Market.
Price Volatility
| VRBC.F volatility | |
|---|---|
| VRBC.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: VRBC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VRBC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 5,459 | Sebastien Huron | corporate.virbac.com |
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners.
Virbac SA Fundamentals Summary
| VRBC.F fundamental statistics | |
|---|---|
| Market cap | US$3.28b |
| Earnings (TTM) | US$131.49m |
| Revenue (TTM) | US$1.35b |
24.9x
P/E Ratio2.4x
P/S RatioIs VRBC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VRBC.F income statement (TTM) | |
|---|---|
| Revenue | €1.25b |
| Cost of Revenue | €433.87m |
| Gross Profit | €813.03m |
| Other Expenses | €691.73m |
| Earnings | €121.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 13, 2024
| Earnings per share (EPS) | 14.49 |
| Gross Margin | 65.20% |
| Net Profit Margin | 9.73% |
| Debt/Equity Ratio | 9.6% |
How did VRBC.F perform over the long term?
See historical performance and comparison